1. Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors

    Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors

    EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on commercializing novel vaccines, today announced Andrew A. F. Hack, M.D., Ph.D., a Managing Director at  Bain Capital Life Sciences, has been appointed to Dynavax’s Board of Directors. The appointment follows an investment by Bain Capital Life Sciences in Dynavax’s recently completed public offering...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned